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CASE REPORT
OPTOCHIASMATIC TUBERCULOMA AS THE SOLE MANIFESTATION OF LATE RECURRENT 
TUBERCULOSIS
Marco A. LIMA(1), Antonio AVERSA(1), Pericles MARANHÃO-FILHO(1), Gabriela A. LIMA(2), Andre CURI(3), Carolina A. SCHMALTZ(4) & Flavia M. SANTANNA(4)
SUMMARY
Brain tuberculomas account for 10-20% of space occupying brain lesions in developing countries. Most lesions are observed at 
time of tuberculosis diagnosis or soon after starting treatment. We herein describe a 32 year-old patient with a 14-month history of 
headache and progressive visual loss. Her past medical history revealed pulmonary tuberculosis treated eight years before. A brain MRI 
showed a T1- and T2-weighted isointense contrast-enhancing lesion in the optic chiasm. A presumptive diagnosis of optochiasmatic 
tuberculoma was made and isoniazid, rifampin, pyrazinamide, and ethambutol were started. Despite treatment, the patient evolved 
to blindness. The prompt recognition of this condition is extremely important since the presence of optochiasmal enhancement is 
associated with blindness in patients with tuberculosis.
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INTRODUCTION
Brain tuberculomas are caseous foci with fibrous encapsulation 
resulting from hematogeneous dissemination of bacilli. They account 
for 0.15-4% of space occupying brain lesions worldwide6, but can 
reach 10-20% in developing countries7. Most lesions are observed at 
time of tuberculosis diagnosis, either meningeal or systemic, or soon 
after starting treatment (paradoxical reaction). They are present in 1% 
of patients with active tuberculosis and up to 28% of patients with 
tuberculous meningitis4. The inflammatory reaction observed in central 
nervous system tuberculosis has a strong predilection for basal parts of 
the brain, especially in interpeduncular, suprasellar and Sylvian cisterns, 
which can result in optochiasmatic arachnoiditis and tuberculoma2. 
Optochiasmatic arachnoiditis and tuberculoma are devastating forms of 
tuberculous meningitis and are often associated with blindness or severe 
vision impairment. We herein describe a patient with optochiasmatic 
tuberculoma as the sole manifestation of tuberculosis reactivation eight 
years after treatment of pulmonary tuberculosis.
CASE REPORT
A 32 year-old lady was seen at the outpatient brain tumor clinic 
at the National Institute of Cancer (Rio de Janeiro, Brazil) due to a 
possible optic chiasm glioma. She reported progressive bilateral visual 
loss over 14 months associated with intense headache and vomiting in 
the last month. She denied fever or any other systemic or neurologic 
complaints. The neurologic examination was unremarkable and the 
first ophthalmic examination revealed no perception of light in the left 
eye and vision 20/60 in the right eye. Her past medical history revealed 
pulmonary tuberculosis treated eight years before. At that time, culture 
from the sputum was positive for M. Tuberculosis in the sputum and 
the isolated strain was sensitive to isoniazid, rifampicin, pyrazinamide, 
ethambutol and etionamide. She was treated with isoniazid, rifampicin 
and pyrazinamide for six months with good compliance and improvement 
of the symptoms. HIV serology was negative at that time as well as at 
the onset of visual complaints.
A brain MRI showed a T1- and T2-weighted isointense contrast-
enhancing lesion in the optic chiasm (Fig. 1). A lumbar puncture 
revealed mild pleocytosis (8 cells/mm3), protein 55 mg/dL and glucose 
40 mg/dL. Stains and cultures for bacteria, mycobacteria and fungi 
were negative. A lung CT scan did not reveal any active tuberculosis 
lesions. A presumptive diagnosis of optochiasmatic tuberculoma was 
made and a four-drug regimen (isoniazid, rifampin, pyrazinamide, and 
ethambutol) was started. The headache and vomiting quickly resolved 
but despite tuberculosis treatment and steroids she evolved to blindness. 
Fourteen months later a new MRI showed complete resolution of the 
lesion.
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DISCUSSION
Vision loss occurs in about 10% and impairment in 27% of patients 
with central nervous system tuberculosis1. It is usually secondary to 
hydrocephalus, optochiasmatic arachnoiditis, optic nerve involvement, 
tuberculomas affecting the optochiasmatic region and ethambutol 
toxicity8. Optochiasmatic tuberculomas are uncommon and can be present 
at diagnosis of pulmonary tuberculosis or develop paradoxically during 
treatment1 raising the question of treatment failure. According to GARG 
et al., a multivariate logistic regression analysis revealed that younger 
age, female gender, and an elevated cerebrospinal fluid protein content 
are associated with development of optochiasmatic tuberculomas2.
An important issue is that as brain tuberculomas can present without 
concomitant meningeal involvement, as observed in our patient, the 
diagnosis becomes even more difficult. They can be easily confounded 
with other space-occupying lesions such as brain abscess, sarcoidosis, 
metastasis or primary brain tumors, especially if the diagnosis of 
tuberculosis was not established in other sites7. Biopsy may be required 
in such cases. Stereotatic biopsy may be superior to open craniotomy 
since it is associated with lesser complications and its diagnostic efficacy 
is around 85%3.
Steroids have been traditionally used in attempt to reduce the 
inflammatory reaction and secondary neurologic damage, but despite 
treatment patients can evolve to complete visual loss. Recently, some 
authors have used thalidomide with improvement of brain lesions and 
recovery of vision5.
The prompt recognition of this condition is extremely important since 
the presence of optochiasmal enhancement is associated with blindness 
in patients with tuberculosis.
RESUMO
Tuberculoma opto-quiasmático como única manifestação de 
tuberculose recorrente tardia
Tuberculomas cerebrais são responsáveis por 10-20% das lesões 
parenquimatosas em países em desenvolvimento. A maioria destas 
lesões é observada ao diagnóstico de tuberculose ou logo após o início 
do tratamento. Descrevemos um caso de uma paciente de 32 anos com 
história de 14 meses de evolução de perda visual progressiva e cefaleia. 
A história patológica revelou tuberculose pulmonar 8 anos antes. A 
ressonância magnética do crânio mostrou uma lesão isointensa nas 
sequências T1 e T2 captantes de contraste no quiasma óptico. Fizemos 
o diagnóstico presuntivo de tuberculoma ótico-quiasmático e inciamos 
isoniazida, rifampicina, pirazinamida e etambutol. Apesar do tratamento, 
a paciente evoluiu para amaurose bilateral. O rápido diagnóstico desta 
condição é extremamente importante já que a presença de captação de 
contraste está associada à amaurose em pacientes com tuberculose. 
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Fig. 1 - Axial (A) and coronal (B) contrast enhanced T1-weighted MRI sequences showing 
an optochiasmatic tuberculoma (white arrows).
